Cargando…

TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples

Summary: Network pharmacology-based prediction of multi-targeted drug combinations is becoming a promising strategy to improve anticancer efficacy and safety. We developed a logic-based network algorithm, called Target Inhibition Interaction using Maximization and Minimization Averaging (TIMMA), whi...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Liye, Wennerberg, Krister, Aittokallio, Tero, Tang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443685/
https://www.ncbi.nlm.nih.gov/pubmed/25638808
http://dx.doi.org/10.1093/bioinformatics/btv067
_version_ 1782373038602321920
author He, Liye
Wennerberg, Krister
Aittokallio, Tero
Tang, Jing
author_facet He, Liye
Wennerberg, Krister
Aittokallio, Tero
Tang, Jing
author_sort He, Liye
collection PubMed
description Summary: Network pharmacology-based prediction of multi-targeted drug combinations is becoming a promising strategy to improve anticancer efficacy and safety. We developed a logic-based network algorithm, called Target Inhibition Interaction using Maximization and Minimization Averaging (TIMMA), which predicts the effects of drug combinations based on their binary drug-target interactions and single-drug sensitivity profiles in a given cancer sample. Here, we report the R implementation of the algorithm (TIMMA-R), which is much faster than the original MATLAB code. The major extensions include modeling of multiclass drug-target profiles and network visualization. We also show that the TIMMA-R predictions are robust to the intrinsic noise in the experimental data, thus making it a promising high-throughput tool to prioritize drug combinations in various cancer types for follow-up experimentation or clinical applications. Availability and implementation: TIMMA-R source code is freely available at http://cran.r-project.org/web/packages/timma/. Contact: jing.tang@helsinki.fi Supplementary information: Supplementary data are available at Bioinformatics online.
format Online
Article
Text
id pubmed-4443685
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-44436852015-06-05 TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples He, Liye Wennerberg, Krister Aittokallio, Tero Tang, Jing Bioinformatics Applications Notes Summary: Network pharmacology-based prediction of multi-targeted drug combinations is becoming a promising strategy to improve anticancer efficacy and safety. We developed a logic-based network algorithm, called Target Inhibition Interaction using Maximization and Minimization Averaging (TIMMA), which predicts the effects of drug combinations based on their binary drug-target interactions and single-drug sensitivity profiles in a given cancer sample. Here, we report the R implementation of the algorithm (TIMMA-R), which is much faster than the original MATLAB code. The major extensions include modeling of multiclass drug-target profiles and network visualization. We also show that the TIMMA-R predictions are robust to the intrinsic noise in the experimental data, thus making it a promising high-throughput tool to prioritize drug combinations in various cancer types for follow-up experimentation or clinical applications. Availability and implementation: TIMMA-R source code is freely available at http://cran.r-project.org/web/packages/timma/. Contact: jing.tang@helsinki.fi Supplementary information: Supplementary data are available at Bioinformatics online. Oxford University Press 2015-06-01 2015-01-31 /pmc/articles/PMC4443685/ /pubmed/25638808 http://dx.doi.org/10.1093/bioinformatics/btv067 Text en © The Author 2015. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Applications Notes
He, Liye
Wennerberg, Krister
Aittokallio, Tero
Tang, Jing
TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples
title TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples
title_full TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples
title_fullStr TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples
title_full_unstemmed TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples
title_short TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples
title_sort timma-r: an r package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples
topic Applications Notes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443685/
https://www.ncbi.nlm.nih.gov/pubmed/25638808
http://dx.doi.org/10.1093/bioinformatics/btv067
work_keys_str_mv AT heliye timmaranrpackageforpredictingsynergisticmultitargeteddrugcombinationsincancercelllinesorpatientderivedsamples
AT wennerbergkrister timmaranrpackageforpredictingsynergisticmultitargeteddrugcombinationsincancercelllinesorpatientderivedsamples
AT aittokalliotero timmaranrpackageforpredictingsynergisticmultitargeteddrugcombinationsincancercelllinesorpatientderivedsamples
AT tangjing timmaranrpackageforpredictingsynergisticmultitargeteddrugcombinationsincancercelllinesorpatientderivedsamples